Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer-Reference-Cited by-同舟云学术

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

Published:2021-12-13 Issue:12 Volume:4 Page:e2138550
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Xiang Michael¹,Ma Ting Martin¹,Savjani Ricky¹,Pollom Erqi L.²,Karnes R. Jeffrey³,Grogan Tristan⁴,Wong Jessica K.⁵,Motterle Giovanni³,Tosoian Jeffrey J.⁶,Trock Bruce J.⁷,Klein Eric A.⁸,Stish Bradley J.⁹,Dess Robert T.¹⁰,Spratt Daniel E.¹⁰,Pilar Avinash¹¹,Reddy Chandana¹²,Levin-Epstein Rebecca¹,Wedde Trude B.¹³,Lilleby Wolfgang A.¹³,Fiano Ryan¹⁴,Merrick Gregory S.¹⁴,Stock Richard G.¹⁵,Demanes D. Jeffrey¹,Moran Brian J.¹⁶,Huland Hartwig¹⁷,Tran Phuoc T.¹⁸,Martin Santiago¹⁹,Martinez-Monge Rafael¹⁹,Krauss Daniel J.²⁰,Abu-Isa Eyad I.¹⁰,Alam Ridwan⁷,Schwen Zeyad⁷,Pisansky Thomas M.⁹,Choo C. Richard⁹,Song Daniel Y.¹⁸,Greco Stephen¹⁸,Deville Curtiland¹⁸,McNutt Todd¹⁸,DeWeese Theodore L.¹⁸,Ross Ashley E.²¹,Ciezki Jay P.¹²,Boutros Paul C.²²,Nickols Nicholas G.¹²³,Bhat Prashant¹,Shabsovich David¹,Juarez Jesus E.¹,Chong Natalie¹,Kupelian Patrick A.¹,Rettig Matthew B.²⁴²⁵,Zaorsky Nicholas G.²⁶,Berlin Alejandro¹¹,Tward Jonathan D.²⁷,Davis Brian J.⁹,Reiter Robert E.²⁸,Steinberg Michael L.¹,Elashoff David⁴,Horwitz Eric M.⁵,Tendulkar Rahul D.¹²,Tilki Derya¹⁷²⁹,Czernin Johannes³⁰,Gafita Andrei³⁰,Romero Tahmineh⁴,Calais Jeremie³⁰,Kishan Amar U.¹

Affiliation:

1. Department of Radiation Oncology, University of California, Los Angeles

2. Department of Radiation Oncology, Stanford University, Stanford, California

3. Department of Urology, Mayo Clinic, Rochester, Minnesota

4. Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California

5. Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania

6. Department of Urology, University of Michigan, Ann Arbor

7. Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland

8. Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio

9. Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota

10. Department of Radiation Oncology, University of Michigan, Ann Arbor

11. Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada

12. Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio

13. Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway

14. Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, West Virginia

15. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, New York

16. Prostate Cancer Foundation of Chicago, Westmont, Illinois

17. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany

18. Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland

19. Department of Oncology, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain

20. Oakland University William Beaumont School of Medicine, Royal Oak, Michigan

21. Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois

22. Department of Human Genetics, University of California, Los Angeles

23. Department of Radiation Oncology, Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles, California

24. Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles

25. Department of Hematology and Oncology, Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles, California

26. Department of Radiation Oncology, Penn State Cancer Institute, Hershey, Pennsylvania

27. Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City

28. Department of Urology, University of California, Los Angeles

29. Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany

30. Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2787066/xiang_2021_oi_211093_1638801464.59627.pdf

Reference25 articles.

1. Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy.;Cagney;BMC Urol,2017

2. Validation of a subclassification for high-risk prostate cancer in a prospective cohort.;Butler;Cancer,2020

3. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.;Pagliarulo;J Clin Oncol,2006

4. Transcriptomic heterogeneity of Gleason grade group 5 prostate cancer.;Kishan;Eur Urol,2020

5. Local failure and survival after definitive radiotherapy for aggressive prostate cancer: an individual patient-level meta-analysis of six randomized trials.;Kishan;Eur Urol,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer;Current Treatment Options in Oncology;2024-01

2. Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: A multivariable model and web-based calculator;Journal of the American Academy of Dermatology;2023-11

3. PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management;Clinical and Translational Imaging;2023-08-30

4. Advances in high-risk localized prostate cancer: Staging and management;Current Problems in Cancer;2023-08

5. Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte;Journal of Translational Medicine;2023-07-12